Abstract

Machine and deep learning in inflammatory bowel disease

Curr Opin Gastroenterol. 2023 Jul 1;39(4):294-300.doi: 10.1097/MOG.0000000000000945. Epub 2023 May 8.

 

Fatima Zulqarnain 1S Fisher RhoadsSana Syed

 
     

Author information

1Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Virginia, USA.

Abstract

Purpose of review: The Management of inflammatory bowel disease (IBD) has evolved with the introduction and widespread adoption of biologic agents; however, the advent of artificial intelligence technologies like machine learning and deep learning presents another watershed moment in IBD treatment. Interest in these methods in IBD research has increased over the past 10 years, and they offer a promising path to better clinical outcomes for IBD patients.

Recent findings: Developing new tools to evaluate IBD and inform clinical management is challenging because of the expansive volume of data and requisite manual interpretation of data. Recently, machine and deep learning models have been used to streamline diagnosis and evaluation of IBD by automating review of data from several diagnostic modalities with high accuracy. These methods decrease the amount of time that clinicians spend manually reviewing data to formulate an assessment.

Summary: Interest in machine and deep learning is increasing in medicine, and these methods are poised to revolutionize the way that we treat IBD. Here, we highlight the recent advances in using these technologies to evaluate IBD and discuss the ways that they can be leveraged to improve clinical outcomes.

 

© Copyright 2013-2023 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.